Hadasit Bio Total Liabilities

Latest as of June 2023: ILA3.73 Million ILA ≈ $9.99K USD

Hadasit Bio total liabilities. Based on the latest financial reports, Hadasit Bio (HDST) has total liabilities worth ILA3.73 Million ILA (≈ $9.99K USD) as of June 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Hadasit Bio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Hadasit Bio (2008–2022)

Total liabilities of Hadasit Bio from 2008 to 2022. This chart illustrates how Hadasit Bio's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Hadasit Bio to see how much of total assets are deployed in long-term investments.

Hadasit Bio Competitors by Total Liabilities

The table below lists competitors of Hadasit Bio ranked by their total liabilities.

Company	Country	Total Liabilities
Braille Energy Systems Inc V:BES	Canada	CA$3.34 Million
Silver Predator Corp V:SPD	Canada	CA$27.90K
Spectra Inc. V:SSA	Canada	CA$201.28K
France Tourisme Immobilier SA PA:MLFTI	France	€6.94 Million
Bluejay Diagnostics Inc NASDAQ:BJDX	USA	$1.42 Million
Cyabra, Inc. Common Stock NASDAQ:CYAB	USA	$14.63 Million
PLAY2CHILL S.A. ZY -10 F:688	Germany	€304.56K

Liability Composition Analysis (2008–2022)

This chart breaks down Hadasit Bio's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Hadasit Bio total assets.

Liquidity & Leverage Metrics

Hadasit Bio Total Liabilities Ratios Explained

Hadasit Bio total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hadasit Bio's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hadasit Bio (2008–2022)

The table below shows the annual total liabilities of Hadasit Bio from 2008 to 2022.

Year	Total Liabilities	Change
2022-12-31	ILA3.88 Million ≈ $10.39K	+436.84%
2021-12-31	ILA722.00K ≈ $1.94K	-83.10%
2020-12-31	ILA4.27 Million ≈ $11.45K	+9.23%
2019-12-31	ILA3.91 Million ≈ $10.49K	+278.61%
2018-12-31	ILA1.03 Million ≈ $2.77K	-86.78%
2017-12-31	ILA7.81 Million ≈ $20.94K	-0.32%
2016-12-31	ILA7.84 Million ≈ $21.01K	-5.69%
2015-12-31	ILA8.31 Million ≈ $22.28K	-19.38%
2014-12-31	ILA10.31 Million ≈ $27.63K	+4.41%
2013-12-31	ILA9.87 Million ≈ $26.46K	+34.76%
2012-12-31	ILA7.33 Million ≈ $19.64K	-8.25%
2011-12-31	ILA7.98 Million ≈ $21.40K	-0.04%
2010-12-31	ILA7.99 Million ≈ $21.41K	+14.84%
2009-12-31	ILA6.96 Million ≈ $18.65K	+100.61%
2008-12-31	ILA3.47 Million ≈ $9.29K	--

About Hadasit Bio

TA:HDST Israel Biotechnology & Medical Research

Market Cap

$1.78 Million

ILA665.31 Million ILA

Market Cap Rank

#30136 Global

#438 in Israel

Share Price

ILA60.00

Change (1 day)

+0.00%

52-Week Range

ILA30.00 - ILA83.00

All Time High

ILA2847.77